SightfileU.S. market data from official filings

Companies › TALK

TALKSPACE INC (TALK)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001803901 · EDGAR filings · Updated 2026-06-22

TALKSPACE INC (TALK) has reported institutional ownership of 77.0%, with 181 institutional managers holding positions valued at $651.8M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
77.0%
Institutional managers
181
Reported 13F value
$651.8M
Insider activity
70 trans.
−$314.5K net selling
Data flags
3 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, TALKSPACE INC has 181 institutional holders and institutional ownership of 77.0%.

Insider activity

Insiders reported 70 transactions (0 buys, 7 sells) across 13 reporting insiders, with a net reported value of −$314.5K.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2023-05-18 (recurring since 2022-11-23) — source filing. The authoritative details are those stated in the filing itself.
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2021-05-18 (recurring since 2021-03-29) — source filing. The authoritative details are those stated in the filing itself.
Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2021-05-05 (recurring since 2021-05-05) — source filing. The authoritative details are those stated in the filing itself.

Related companies

BRIGHT MINDS BIOSCIENCES INC (DRUG) · GH RESEARCH PLC (GHRS) · SPYGLASS PHARMA INC (SGP) · AVANOS MEDICAL INC (AVNS) · AMPHASTAR PHARMACEUTICALS INC COM (AMPH) · ARBUTUS BIOPHARMA CORP (ABUS)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-22.